首页>
外国专利>
Humanized type ii anti-cd20 antigen binding molecules and use thereof for the manufacture of a medicament to treat b-cell proliferative disorders or autoimmune diseases
Humanized type ii anti-cd20 antigen binding molecules and use thereof for the manufacture of a medicament to treat b-cell proliferative disorders or autoimmune diseases
The present invention relates to antigen binding molecules (ABMs). In particular embodiments, the present invention relates to recombinant monoclonal antibodies, including chimeric, primatized or humanized antibodies specific for human CD20. In addition, the present invention relates to nucleic acid molecules encoding such ABMs, and vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the ABMs of the invention, and to methods of using these ABMs in treatment of disease. In addition, the present invention relates to ABMs with modified glycosylation having improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.
展开▼